Invention Grant
- Patent Title: Malignant tumor target peptide
-
Application No.: US16326120Application Date: 2017-08-16
-
Publication No.: US10695396B2Publication Date: 2020-06-30
- Inventor: Michiko Fukuda , Motohiro Nonaka
- Applicant: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
- Applicant Address: JP Tokyo
- Assignee: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
- Current Assignee: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
- Current Assignee Address: JP Tokyo
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4d7b3d7c
- International Application: PCT/JP2017/030003 WO 20170816
- International Announcement: WO2018/034356 WO 20180222
- Main IPC: A61K38/03
- IPC: A61K38/03 ; A61K38/06 ; A61K49/04 ; A61K49/14 ; A61P35/00 ; A61K49/06 ; C07K14/00 ; A61K45/00 ; C07K19/00 ; C07K7/06 ; C07K5/08 ; C07K5/10 ; A61K47/64 ; A61K49/08 ; C12N15/09

Abstract:
The present invention provides a peptide comprising the amino acid sequence of any of the formulas (I)-(III) below: (I) an amino acid sequence of (X1)[D]P[D](X2)[D] wherein X1 is W or F, X2 is S or T, and each amino acid symbol immediately followed by symbol [D] is a D form of the amino acid, (II) an amino acid sequence of P[D]T[D](X)n F[D] wherein (X)n is any amino acid in the number of n selected independently of each other, n is an integer of 0-4, and the symbol [D] is as defined above, (III) an amino acid sequence that is a Retro-inverso of the amino acid sequence of any of the aforementioned (I) and the aforementioned (II); and a conjugate containing the peptide and a functional part.
Public/Granted literature
- US20190175684A1 MALIGNANT TUMOR TARGET PEPTIDE Public/Granted day:2019-06-13
Information query
IPC分类: